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Background: Visceral leishmaniasis is the most serious form of leishmaniasis and can be lethal if left untreated. Currently
available treatments for these parasitic diseases are frequently associated to severe side effects. The leaves of Croton
cajucara are used as an infusion in popular medicine to combat several diseases. Previous studies have demonstrated that
the linalool-rich essential oil from C. cajucara (white sacaca) is extremely efficient against the tegumentary specie
Leishmania amazonensis. In this study, we investigated the effects of the 7-hydroxycalamenene-rich essential oil from the
leaves of C. cajucara (red sacaca) against Leishmania chagasi, as well as on the interaction of these parasites with host cells.
Methods: Promastigotes were treated with different concentrations of the essential oil for determination of its minimum
inhibitory concentration (MIC). In addition, the effects of the essential oil on parasite ultrastructure were analyzed by
transmission electron microscopy. To evaluate its efficacy against infected cells, mouse peritoneal macrophages infected
with L. chagasi promastigotes were treated with the inhibitory and sub-inhibitory concentrations of the essential oil.
Results: The minimum inhibitory concentrations of the essential oil and its purified component 7-hydroxycalamenene
against L. chagasi were 250 and 15.6 μg/mL, respectively. Transmission electron microscopy analysis revealed important
nuclear and kinetoplastic alterations in L. chagasi promastigotes. Pre-treatment of macrophages and parasites
with the essential oil reduced parasite/macrophage interaction by 52.8%, while it increased the production of
nitric oxide by L. chagasi-infected macrophages by 80%.
Conclusion: These results indicate that the 7-hydroxycalamenene-rich essential oil from C. cajucara is a promising
source of leishmanicidal compounds.Background
Human visceral leishmaniasis (HVL) or kala-azar is an
often lethal infectious disease. About 500,000 new cases
of visceral leishmaniasis are reported worldwide each
year [1]. In Brazil, approximately 4,000 people are
infected with leishmaniasis each year, and 10.5% die
from the disease. The disease is more common in the
Northeastern part of the country, but it extends to* Correspondence: abvermelho@micro.ufrj.br
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reproduction in any medium, provided the ortropical forest regions and to some major industrial cit-
ies in the Southeastern region [2,3].
Conventional chemotherapy, one of the most common
treatments for leishmaniasis, is highly toxic and fails in ap-
proximately 10% of cases [2]. Among the chemotherapeu-
tic agents used to treat the disease, the pentavalent
antimonials are still the first choice. However, the current
scenario of drug development for leishmaniasis is more
promising than a few decades ago. Recently, potential
therapies for visceral leishmaniasis have been introduced,
including liposomal amphotericin B, paromomycin, and
miltefosine [4]. Despite the advances, both the conven-
tional treatments and the new chemotherapeutic agentsral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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side effects and high cost.
Given the limitations of treatment against visceral
leishmaniasis, there is a need for development of new
drugs. The use of antimicrobials and other drugs derived
from plants has been considered promising. Croton
cajucara Benth. (family Euphorbiaceae), locally known
as “sacaca”, is a plant found in the Amazon region that
has been used in folk medicine against gastrointestinal
and liver disorders, diabetes, and for cholesterol reduc-
tion. Two morphotypes were identified, namely white
sacaca and red sacaca [5,6]. The essential oils of white
sacaca and red sacaca were classified in two groups: one
rich (up to 45%) in linalool [7], and other containing up
to 44% of an aromatic sesquiterpene, isolated and identi-
fied by NMR as 7-hydroxycalamenene (Figure 1) [8].
Prompted by the fact that the essential oils extracted from
leaves of white and red sacaca present antimicrobial
properties, being effective against several microorganisms,
including L. amazonensis [9], Staphylococcus aureus MRSA,
Mycobacterium smegmatis, M. tuberculosis, Rhizopus oryzae,
and Candida albicans [5-7], we decided to investigate the
effects of the 7-hydroxycalamenene-rich essential oil of red
sacaca against Leishmania chagasi parasites. In addition,
the effects of the essential oil on the interaction of these
parasites with mammalian host cells were evaluated.Methods
Chemicals
Culture media were purchased from Difco (Sparks, MD
21152, USA). Reagents used in electrophoresis and mo-
lecular mass standards were acquired from AmershamFigure 1 Chemical structure of 7-hydroxycalamenene.Life Science (Little Chalfont, England). All other reagents
were analytical grade.Plant material, essential oil extraction and 7-
hydroxycalamenene purification
All samples were kept in a germplasm bank under the
same cultivation practices. Leaves of C. cajucara were col-
lected between 08:00 and 09:00 AM. Voucher specimens
were deposited at the Embrapa Occidental Amazon
Herbarium (registry IAN 165013). The oils were obtained
by hydrodistillation in a modified Clevenger apparatus for
4 hours, carefully separated, and stored in opaque glass
vials in a refrigerator (−10°C) prior to analysis and bio-
logical assays [7].
The isolation of 7-hydroxycalamenene was performed
by preparative column chromatography on silica gel
(Merck, 70–230 mesh), eluting with hexane and hexane-
ethyl acetate mixtures.Analysis of the essential oil by GC-MS
The essential oils were analyzed at GC-MS under the
following conditions: the oven temperature was pro-
grammed from 60°C to 240°C at 3°C/min, and helium
was the carrier gas (at 1.0 mL/min). One microliter of
1% solution of the oil in dichloromethane was injected
in split mode (1:100). Mass spectra were obtained in an
Agilent 5973N system, fitted with a low bleeding 5%
phenyl/95% methylsilicone (HP-5 MS, 30 m × 0.25 mm ×
0.25 μm) fused silica capillary column, operating in elec-
tronic ionization mode (EI) at 70 eV, with scan mass range
of 40–500 m/z. Sampling rate was 3.15 scan/s. Ion source
was kept at 230°C, mass analyzer at 150°C, and transfer
line at 260°C. Linear retention indices (LRI) were mea-
sured by injection of a series of n-alkanes (C7-C30) in the
same column and conditions as described above and com-
pared with reference data [8].Analyses of 7-hydroxycalamenene by GC
In order to evaluate the degree of purity of the isolated
material, 7-hydroxycalamenene was analyzed on an
Agilent (Palo Alto, CA, USA) 6890N gas chromatograph
fitted with a 5% phenyl—95% methylsilicone (HP-5,
30 m × 0.32 mm × 0.25 μm) fused silica capillary
column. The oven temperature was programmed from
60°C to 240°C (3°C/min), and hydrogen was used as car-
rier gas (1.4 mL/min). It was injected 1.0 μL of a 1% so-
lution of the 7-hydroxycalamenene in dichloromethane,
in split mode (1:100). Injector was kept at 250°C and de-
tector (FID) at 280°C. All analyses were performed in
triplicate.
The percentage was calculated as % peak area of GC–
FID. The material purity was over 80%.
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Promastigote forms of Leishmania (L.) chagasi MHOM/
BR/1974/PP75 were obtained from Leishmania Type Cul-
ture Collection (LTCC) of Oswaldo Cruz Institute/Fiocruz
(Rio de Janeiro, RJ, Brazil). Parasites were maintained by
weekly transfers in PBHIL medium supplemented with
10% fetal bovine serum (FBS), at 28°C [10]. Parasites were
maintained infective by periodical macrophage infection.
Antileishmanial activity
To evaluate the minimum growth-inhibitory concentra-
tion (MIC), promastigote forms of L. chagasi (106 para-
sites/mL) were incubated in fresh medium in the presence
of several concentrations (1–1000 μg/mL) of essential oil
and its 7-hydroxycalamenene-rich purified fraction (80%).
After 120 h incubation, parasite viability was determined
using the microplate method based on the reduction of
resazurin as described [11]. Alternatively, cells were
centrifuged and washed three times in PBS (150 mM
NaCl; 20 mM phosphate buffer, pH 7.2) and resuspended
in fresh culture medium without the plant extract, to
evaluate the leishmanicidal or leishmanistatic effect. The
50% lethal dose (LD50) was determined by logarithmic re-
gression analysis of the data obtained as described above.
Transmission electron microscopy
Parasites at early stationary phase of growth were
harvested, washed twice with PBS, and incubated or not
with 250 μg/mL (MIC concentration) of the essential oil
at 28°C for 24 hours. Cells were washed twice in PBS
and then fixed with 2.5% glutaraldehyde in 0.1 M so-
dium cacodylate buffer containing 3.5% sucrose, pH 7.4,
at 4°C for 60 min. Parasites were then rinsed in PBS pH
7.4 and pelleted by centrifugation. The pellets were then
post-fixed with a 1% osmium tetroxide and potassium
ferrocyanide solution for 1 hour, dehydrated sequentially
in acetone, and then embedded in Epon 812. Ultrathin
sections were cut using an LKB ultramicrotome and col-
lected on copper grids. Sections were stained with uranyl
acetate and lead citrate and were observed in a Jeol
JEM1011 transmission electron microscope.
Peptidase activity of Leishmania chagasi by gelatin–SDS-
PAGE
Promastigote forms of L. chagasi (2.0x106 parasites/mL)
were harvested at the log phase of growth, washed two
times in PBS by centrifugation, and then incubated in
PBS pH 6.8 with the essential oil (250 μg/mL) at 28°C
for 1 hour. Controls were prepared without the essential
oil. Cells were centrifuged and the supernatants col-
lected and concentrated by dialysis (cut-off 9000 Da)
against polyethylene glycol 4000 for 12 hours at 4°C.
Cells were disrupted at 4°C by four 15-s periods of ultra-
sound treatment with 1-min intervals. The extracts werecentrifuged and supernatant aliquots were stored at −60°C.
Polyacrylamide gels containing 0.2% copolymerized gel-
atin as substrate were loaded with 28 μg of proteins
(cellular extract and supernatants) per slot. After elec-
trophoresis at a constant voltage of 200 V at 4°C, gels
were soaked in 2.5% Triton X-100 (1 h) to remove SDS,
and then incubated for 18 h at 37°C in 0.1 M phosphate
buffer, pH 5.5, in the absence or in the presence of prote-
ase inhibitors (1 mM E-64 and 1 mM phenanthroline).
Gels were stained for 1 h with 0.2% Comassie brilliant
blue R-250 in methanolacetic acid-water (50:10:40) and
de-stained to expose proteolytic bands in the same solv-
ent. The relative molecular mass of the peptidases was cal-
culated by comparison with the mobility of low molecular
mass standards. Peptidase activity was estimated by the in-
tensity of the bands using ImageJ program (NIH).
Peritoneal mouse macrophages and cytotoxity assay
Female Swiss mice (6–8 weeks old) from a colony at the
General Microbiology Department/UFRJ animal house
facility were used in all of the experiments. The animals
were maintained at 21 ± 2°C, on a 12hs light/dark cycle,
with food and water until 1 h prior to the experimental
procedures. The animals were killed according to the
federal guidelines and institutional policies by cervical
dislocation. The procedures were approved by the
Fiocruz Commitee of Ethics for the Use of Animals
(resolution 242/99, license LW 2/12). Peritoneal mouse
macrophages were collected in cold PBS and allowed to
adhere onto coverslips placed in 24-well culture plates, for
30 min at 37°C and 4% CO2. For the cytotoxity assay, 10
5
macrophages/well were incubated with different concen-
trations of the C. cajucara essential oil (1–1000 μg/mL)
at 37°C and 5% CO2 for 48 h. Cell viability was
assessed after 4 h incubation with resazurin as de-
scribed by Al-Musayeib et al. [12].
Macrophage infection and NO production
Parasites and/or peritoneal mouse macrophages were
pretreated with 250 and 125 μg/ml (MIC and subMIC)
of red sacaca essential oil. After 20 min, adherent cul-
tured macrophages and free parasites were washed once,
resuspended in fresh RPMI culture medium, and then
co-cultured at a ratio of 10 promastigotes to 1 macro-
phage at 37°C for 120 min in a 4% CO2 atmosphere.
Cells were fixed and Giemsa stained, and the percentage
of infected macrophages was determined by counting
600 cells. The association indices were determined by
multiplying the percentage of infected macrophages by
the mean number of parasites per infected cell. The as-
sociation index was considered as the number of para-
sites that successfully infected macrophages. Nitrite
levels in culture supernatants of macrophages infected
or not with L. chagasi were analyzed by Griess reaction
Table 1 In vitro activity of C. cajucara (red sacaca)
essential oil and its purified 7-hydroxycalamenene-rich
fraction against L. chagasi promastigotes and toxicity
profile in mouse peritoneal macrophages
Substance tested L. chagasi Cytotoxicity
[μg/mL]MIC [μg/mL] IC50 [μg/mL]
Essential oil 250 66.7 >500
7-hydroxycalamenene
purified fraction
15.6 1.37 >500
Amphotericin B 0.625 0.01 14.6
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was measured, and the concentration of nitrite was cal-
culated using a linear regression of a standard curve.
Anti-intracellular amastigote activity
The effects of the essential oil from red sacaca (250 and
125 μg/mL) on intracellular amastigotes were deter-
mined after treatment of pre-infected macrophages as pre-
viously described with slight modifications [13]. Briefly,
mouse peritoneal macrophages were infected with L.
chagasi promastigotes (logarithmic growth phase) as de-
scribed above. Next, free promastigotes were removed by
extensive washing with PBS and the infected macrophages
were then incubated for 24 h to allow complete
promastigote differentiation into intracellular amastigotes.
Then, MIC and subMIC concentrations of the essential
oil were added to the cultures of infected macrophages for
20 min. After treatment, supernatants were collected for
the analysis of NO production and coverslips were fixed
as previously described above.
All experiments were performed in triplicate. All results
are presented as the mean and standard error of the mean
(SEM). Normalized data were analyzed by one-way
analysis of variance (ANOVA), and differences between
groups were assessed using the Student-Newman-Keuls
post-test. Results were considered significant at p ≤ 0.05.
Results and discussion
The crucial role that traditional medicine plays in health
care of people living in developing countries is recog-
nized worldwide. For centuries, traditional medicine was
the only health care system available for the prevention
and treatment of several diseases in different cultures
[14]. The research on natural products around the world
has found literally thousands of phytocompounds that are
biologically active against various a number of illnesses,
including infectious diseases. In this study, we described
the cytocidal activity of the 7-hydroxycalamenene-rich es-
sential oil from C. cajucara, red sacaca, against the etio-
logical agent of Kala-azar, L. chagasi.
Most research efforts into the effects of plants on
parasite infections have been carried out using aqueous
or alcoholic extractions, but purified plant essential oils
are also effective in the treatment and prevention of
parasitic diseases [15]. Indeed, the essential oils consti-
tute a potential source of bioactive compounds against
Leishmania species. The linalool-rich essential oil of C.
cajucara, white sacaca, has been previously described as
a potent agent against L. amazonensis [9]. The essential
oil eliminated 100% of the promastigote and amastigote
forms of L. amazonensis at a concentration of 15 ng/mL.
These results encouraged us to extend the study of the
antiprotozoal activity of another C. cajucara morphotype,
red sacaca, rich in 7-hydroxycalamenene, against L.chagasi. The minimum inhibitory concentration (MIC) of
C. cajucara essential oil and its 7-hydroxycalamenene
purified fraction against L. chagasi promastigotes was 250
and 15.6 μg/mL, respectively (Table 1). After 70 min of
treatment, all parasites were destroyed by the MIC of the
essential oil (IC50 = 66.7 μg/mL). Several essential oils
extracted from different plants have shown antileishmanial
activities. A progressive inhibition of parasites was ob-
served when promastigote and amastigote forms of L.
amazonensis were treated with 100 μg/mL of the eugenol-
rich essential oil from Ocimum gratissimum (white
basil) and its major compound [16]. Cymbopogon
citratus (lemon grass) showed a marked effect on the
viability of L. infantum (IC50/ 24 h = 25 μg/mL), L.
tropica (IC50/ 24h = 52 μg/mL), and L. major (IC50/ 48h =
38 μg/mL) promastigotes [17]. Echinops kebericho exerted
a potent leishmanicidal effect against L. donovani and
L. aethiopica species, with MIC values of 0.0765 μg/mL
and 0.0097 μg/mL, respectively [18]. The mechanisms
underlying the antileishmanial activity of essential oils
are not fully understood. Their lipophilic character, as
well as that of their constituents, are possibly involved
in the antimicrobial mechanisms by permeating cell
membranes and disrupting the structure of the different
layers of membrane polysaccharides, fatty acids, and
phospholipids, leading to serious cell damage [19].
Photomicrographs of L. chagasi treated with 250 μg/mL
of the essential oil from C. cajucara are shown in Figure 2
A to H. Depending on the period of treatment, the para-
sites showed different degrees of cell damage. Within the
first 5 min of incubation, increased mitochondrial vol-
ume and loss of mitochondrial cristae can be observed
(Figure 2C), as well as the presence of vacuoles in the
flagellar pocket (Figure 2D). Mitochondrial damage was
followed by kDNA fragmentation and condensation of
nuclear chromatin (Figures 2E-F), although no changes
were observed in the shape of the nucleus. After 30 min
of treatment, the cells exhibited complete disorganization
of the cytoplasmic organelles (Figure 2G). In addition, di-
lated mitochondria (*), flagellar pocket with intense re-
lease of vesicles, and numerous vesicles in the cytoplasm
are noted. Similar mitochondrial swelling and important
Figure 2 (See legend on next page.)
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Figure 2 Ultrastructure alterations induced by the essential oil from Croton cajucara in L. chagasi promastigotes. (A-B) Sections of
untreated promastigote forms showing the main structures observed under transmission electron microscopy. (A) Normal flagellum (F) and
flagellar pocket (FP) are observed in the anterior portion of the parasite. The nucleus (N) is round and the mitochondrion (M) is branched and
observed along the parasite body, next to the cell surface (head arrows); (B) Detail of the mitochondrion containing the kinetoplast (K) with the
array of DNA filaments (arrows); (C-H) Parasites treated for 5 (C-D), 15 (E-F), and 30 (G-H) min with 250 μg/mL of essential oil, showing different
degrees of cell damage. (C) Parasite presenting dilated mitochondria (*) and condensed nuclear chromatin; (D) In the detail, the flagellar pocket
showing intense release of vesicles (stars); (E) Increased mitochondrial volume and loss of cristae (*) and nuclear chromatin condensation
(arrows); (F) Increased mitochondrial volume (*) and kDNA fragmentation (arrows) can be noted. (G-H) Parasites also exhibit dilated mitochondria
(*), condensed nuclear chromatin, flagellar pocket (FP) with intense release of vesicles, and numerous vesicles in the cytoplasm.
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plast chromatin were observed when L. amazonensis was
treated with linalool-rich essential oil from C. cajucara
[9]. Also, the essential oil of C. citratus and its major com-
ponent citral induced changes in the morphology and
ultrastructure of L. amazonensis promastigotes, such as
mitochondrial swelling, the presence of two or more fla-
gella, and exocytic projections in the flagellar pocket [20].
Such types of ultrastructural alterations in L. amazonensis
have been reported to be associated with the depletion of
ergosterol and the alteration of physical properties of the
membrane [21]. Indeed, the inhibitory activity of the ses-
quiterpene nerolidol in the initial steps of the mevalonate
pathway, consequently inhibiting isoprenoid biosynthesis
(dolichol, ubiquinone, and ergosterol), has been previously
demonstrated [22]. Based on the ultrastructural alterations
reported here, it is possible that the 7-hydroxycalamenene-
rich essential oil from C. cajucara exerts similar inhibitory
effect on the biosynthesis of isoprenoids. The inhibitory ef-
fects of natural products on trypanosomatids enzymes have
been reviewed recently [23], highlighting a modern ap-
proach to the discovery of new drugs against trypanosom-
iasis and leishmaniasis.
As shown in Figure 2D, the presence of vacuoles in
the flagellar pocket region of treated promastigotesFigure 3 Peptidase activity of L. chagasi promastigotes treated with t
(control); Lanes 2–4, lysates of parasites treated for 20 (Lane 2), 40 (Lane 3),
supernatant from untreated parasites (control); Lanes 6–8, supernatants fro
with the essential oil.indicates an intense exocytic activity. This was con-
firmed by analyzing the presence of peptidases in the su-
pernatants from parasites treated with 250 μg/mL of the
essential oil. The analysis of peptidase activity revels that
one-hour exposure to the essential oil increased the activity
(41%) of only one group of peptidases of 54 kDa (Figure 3).
L. chagasi promastigote lysates presented a similar 54 kDa
protein band, but no significant difference in peptidase ac-
tivity was noted between treated and untreated cells. The
inhibitory effect of E-64 and phenanthroline on L. chagasi
proteolytic activity confirmed that e 54- and the 41.5-kDa
peptidases belong to cysteine peptidases class. The exocytic
activity of L. amazonensis treated with parthenolide, a ses-
quiterpene lactone isolated from Tanacetum parthenium,
has been previously described [24] as an attempt of cell
survival. High levels of enzymatic activity were detected in
cell lysates but, unlike in our study, the enzymatic activity
was not evaluated in the supernatants from parasites.
Some essential oils from plants have immunomodula-
tory effects that are useful in the treatment of infectious
diseases, particularly when oils cause no adverse effects
to the host. All concentrations of the essential oil from
red sacaca used in this study did not show toxicity to
mouse peritoneal macrophages. Figure 4 shows the ef-
fects of the essential oil on L. chagasi–macrophagehe essential oil from C. cajucara. Lane 1, untreated parasite lysates
and 60 min (Lane 4) with 250 μg/mL of the essential oil. Lane 5,
m parasites treated for 20 (Lane 6), 40 (Lane 7), and 60 min (Lane 8)
0 20 40 60 80
MØ+P
PtMØ+P 
MØ+PtP
PtMØ+PtP
IMØ
Post-IMØ
MIC [250 µg/mL]
subMIC [125 µg/mL]
Control
Association index 
Figure 4 Effects of 7-hydroxycalamenene-rich essential oil extracted from C. cajucara on the interaction of L. chagasi with mouse
peritoneal macrophages. Parasites and/or macrophages were treated with MIC (250 μg/mL) or subMIC (125 μg/mL) of red sacaca essential oil
20 min prior to macrophage–parasite interaction. In addition, macrophages previously infected with L. chagasi were treated with the essential oil
for 20 min and then incubated for 90 min at 37°C in a 5% CO2 atmosphere. After 120 min of interaction, association indices were determined by
counting 600 cells in triplicate coverslips. Each bar represents the mean ± standard error from at least three independent experiments, each
performed in triplicate. (MØ) macrophages; (P) parasites; (PtMØ) pre-treated macrophages; (PtP) pre-treated parasites; (IMØ) infected
macrophages; (Post-IMØ) post-treated infected macrophages.
0 20 40 60 80 100
MØ+P 
PtMØ+P 
MØ+PtP 
PtMØ+Pt
PtMØ 
MØ 
IMØ 
Post-IMØ 
MIC [250 µg/mL] 
subMIC [125 µg/mL] 
Control 
Nitrite (µM) 
Figure 5 Effects of 7-hydroxycalamenene-rich essential oil extracted from C. cajucara on nitric oxide production by infected mouse
peritoneal macrophages. Parasites and/or macrophages were treated with MIC (250 μg/mL) or subMIC (125 μg/mL) of red sacaca essential oil
20 min prior to macrophage–parasite interaction. In addition, macrophages previously infected with L. chagasi were treated with the essential oil
for 20 min and then incubated for 120 min at 37°C in a 5% CO2 atmosphere. The supernatants from controls (untreated cultures) and L. chagasi-
infected macrophages were collected, and the nitrite concentration was determined by the Griess reaction. Each bar represents the mean ±
standard error from at least three independent experiments, each performed in triplicate. (MØ) macrophages; (P) parasites; (PtMØ) pre-treated
macrophages; (PtP) pre-treated parasites; (IMØ) infected macrophages; (Post-IMØ) post-treated infected macrophages.
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association index but it also increased NO production
by infected macrophages (Figure 5). In the present work,
we observed that pretreatment of macrophages with 250
and 125 μg/mL of essential oil reduced the number of
adherent and internalized parasites (Association Indices)
in 30.0 and 9.6%, respectively. In these conditions, NO
production was 41.1 and 36.3% higher, respectively. Pre-
treatment of parasites with the same concentrations of
the essential oil decreased the association indices by 29.4
and 16.1% and increased NO production by 80.4 and
10%, respectively. Pre-treatment of both promastigotes
and macrophages reduced the association indices by
52.8 and 28%, and increased NO production by 80 and
32.5%, respectively. When macrophages were pre-
infected with L. chagasi for 24 hours and then treated
with 250 μg/mL of the essential oil, the association index
was 32.7% lower and NO production was 100% higher
than control. Similar effects on L. amazonensis–macro-
phage interaction have been previously demonstrated for
white sacaca [9], basil [16], and lemongrass essential oils
[20]. Furthermore, the addition of Aloe vera exudate to
L. donovani-infected macrophages significantly increased
NO production compared to untreated macrophages [25].
On the other hand, despite its potent leishmanicidal activ-
ity, the essential oil from Chenopodium ambrosioides has
been shown to inhibit the phagocytic activity of L.
donovani-infected macrophages by only 17.6% [26].
Most of the conventional antileishmanial drugs exhibit
strong in vitro activity against the parasites but they are
also highly toxic for mammalian host cells. By contrast,
several studies have demonstrated that crude essential oils
and their major compounds present low or no toxicity to
host cells at the effective concentrations [27-30]. Both the
essential oil and its 7-hydroxycalamenene-rich purified
fraction presented no toxicity for peritoneal mouse mac-
rophages at the concentrations used in this study.
Conclusion
Our results further support the antileishmanial activity of
7-hydroxycalamenene-rich essential oil of C. cajucara (red
sacaca) leaf extracts. Its toxicity against L. chagasi, with no
effect on mammalian cells, indicates that this essential oil
is a promising source of antileishmanial agents. Further
studies, including in vivo bioassays, are needed to validate
the in vitro results and to ascertain the safety of the essen-
tial oil and the 7-hydroxycalamenene purified fraction.
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